Hypertension. I10
Conditions
Interventions
Intervention 1: Intervention group: The training group will do 12 weeks and 3 sessions of resistance training program every week. Resistance exercises include 9 exercises (2 sets/12-15 repetitions) pl
Sponsors
University of Tehran
Eligibility
Sex/Gender
Male
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Men aged between 55 and 70 years Hypertensive Taking hypertension drugs Completion of the informed consent form
Exclusion criteria
Exclusion criteria: using beta blockers drugs having a history of heart surgery suffering from metabolic diseases alcohol participating in regular physical activities in the six months before the time of the study smoking suffering from inflammatory diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic an diastolic blood pressure. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: Sphygmomanometer and stethoscope.;Serum leptin levels. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: Using the human ELISA diagnostic kit related to the variable.;Adiponectin. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: Using the human ELISA diagnostic kit related to the variable. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight changes. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: scale.;Waist to hip ratio. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: tape meter.;Body mass index. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: Bioelectrical impedance device.;Fat index. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of exercise or supplementation. Method of measurement: Bioelectrical impedance device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Hoshmand moghaddam
Ferdowsi University of Mashhad
Outcome results
None listed